Purpose: Implantable venous ports provide durable intravenous access but carry inherent risks. This study aimed to characterise portacath complication rates at our institution over eight years and to assess the impact of the COVID19 pandemic. Methods: We retrospectively reviewed 344 consecutive patients who underwent port placement at the University of Pécs between 1 March 2018 and 29 November 2025. Data collected included demographics, underlying malignancy, comorbidities, immunocompromise and timing of implantation relative to chemotherapy. Complications were recorded and classified as acute or delayed. Associations between patient factors and complications were analysed using descriptive statistics and χ2 tests. Results: Overall, 31 of 344 ports developed complications, resulting in a complication rate of 9.25%. Infections (8.95%) and skin breakdown or decubitus ulcers (7.63%) were the most common events, while mechanical failure, catheter malposition, and pneumothorax occurred only rarely. Complication rates did not differ significantly by age, sex, comorbidities, immunocompromised status, timing of implantation or pandemic period. Conclusions: At our centre, ultrasound-guided portacath implantation was associated with a low complication rate, even during the COVID19 pandemic. Complications were primarily infectious or cutaneous and showed no clear association with demographic variables or timing of insertion. Rigorous aseptic technique, meticulous surgical placement and comprehensive patient education are essential to minimise adverse events.